La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Mirion Technologies a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Mirion Technologies..

Mirion Technologies (NYSE:MIR) Azioni, Catena delle Opzioni

Mirion Technologies

Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.

Mirion Technologies, Inc. Class A Common Stock

Mirion Technologies Inc

Mirror Protocol - United States Dollar

MIRA Pharmaceuticals, Inc. - Common Stock

Mira Pharmaceuticals Inc

MIRAI Corp

Mirum Pharmaceuticals, Inc. - common stock

Mirum Pharmaceuticals Inc

Miromatrix Medical Inc

SERRANO RES LTD by Serrano Resources Ltd.

Serrano Resources Ltd

Shares of Genius Sports Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GENI#NYSE">GENI</a>) dropped 13.4% to $9.54 on Tuesday after the company reported a slight first-quarter revenue miss, posting $143.99 million against analysts' estimates of $144.06 million.
Despite the revenue miss, the company <a href="https://www.benzinga.com/pressreleases/25/05/b45216981/genius-sports-increases-first-quarter-group-revenue-and-group-adj-ebitda-by-20-and-188-respectivel">beat EPS expectations</a>, reporting a loss of 3 cents per share, narrower than the 4 cents projected and an improvement from last year&#8217;s 11 cent loss. 
What To Know: Revenue rose 20% year-over-year, driven by a 44% jump in its core betting technology segment, though media-related revenue declined 27%. Adjusted EBITDA soared 188% to $19.8 million, with margins expanding to 13.7%. 
Genius <a href="https://www.benzinga.com/pressreleases/25/05/b45216981/genius-sports-increases-first-quarter-group-revenue-and-group-adj-ebitda-by-20-and-188-respectivel">reaffirmed</a> its 2025 revenue guidance of $620 million, signaling confidence in sustained growth, profitability, and cash flow. CEO Mark Locke emphasized continued momentum in technology and product innovation. 
The company also announced a $100 million share repurchase program. Recent initiatives include expanding fan engagement tools and securing exclusive NCAA data rights through 2032.
Read Also: <a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45220645/us-trade-deficit-soars-to-record-140b-as-imports-rocket-ahead-of-trumps-tariffs">US Trade Deficit Soars To Record $140B As Imports Rocket Ahead Of Trump&#8217;s Tariffs</a>
<h2 class="wp-block-heading">How To Buy GENI Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Genius Sports&#8217; case, it is in the Consumer Discretionary sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, GENI has a 52-week high of $11.40 and a 52-week low of $5.03.

News

GENI

Genius Sports (GENI) Shares Slide After Q1 Sales Miss: What's Going On?

IQVIA Holdings Inc&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IQV#NYSE">IQV</a>) reported a first-quarter 2025 adjusted EPS of $2.70, up from $2.54, beating the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of $2.63</a>.
Provider of advanced analytics reported sales of $3.83 billion, beating the <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/b45217013/iqvia-reports-first-quarter-2025-results" rel="noreferrer noopener">consensus of $3.77 billion</a>.
Revenue increased 2.3% on a reported basis and 3.0% at constant currency.
<ul>
<li>Technology &amp; Analytics Solutions (TAS) revenue of $1.55 billion grew 6.4% on a reported basis and 7.6% at constant currency.</li>
<li>Research &amp; Development Solutions (R&amp;DS) revenue of $2.10 billion increased 0.3% on a reported basis and 1.1% at constant currency. Excluding reimbursed expenses, R&amp;DS revenue grew 1.2% on a reported basis.</li>
<li>Contract Sales &amp; Medical Solutions (CSMS) revenue of $181 million, down 4.2% on a reported basis and 2.1% at constant currency.</li>
</ul>
Also Read: <a target="_blank" href="https://www.benzinga.com/news/large-cap/25/02/43945075/dan-loeb-adjusts-healthcare-holdings-danaher-stake-trimmed-as-thermo-fisher-gains-favor" rel="noreferrer noopener">Dan Loeb Adjusts Healthcare Holdings: Danaher Stake Trimmed As Thermo Fisher Gains Favor</a>
As of March 31, 2025, R&amp;DS contracted backlog, including reimbursed expenses, was $31.5 billion, growing 4.8 percent year-over-year and 4.6 percent at constant currency. The company expects approximately $7.9 billion of this backlog to convert to revenue in the next twelve months. First quarter net new bookings were $2.1 billion, representing a book-to-bill ratio of 1.02x and resulting in a trailing twelve-month book-to-bill ratio of 1.14x.
&#8220;IQVIA delivered strong revenue and profit performance, at the high-end of our expectations,&#8221; said Ari Bousbib, chairman and CEO of IQVIA. &#8220;In the clinical trial business, we experienced delayed decision-making by customers on new programs, reflecting incremental macroeconomic and industry sector uncertainty. Despite the environment, our R&amp;DS forward-looking indicators such as qualified pipeline, RFP flow, and backlog continued to grow. On the commercial side, the TAS business delivered above target performance, with revenue growth of 7.6 percent at constant currency. Our strong financial results demonstrate that we are navigating the current market conditions more effectively than our sector, reflecting the scale and strength of our differentiated portfolio and the resilience of our operational execution.&#8221;
Guidance:&nbsp;IQVIA Holdings raises its 2025 outlook for sales from $15.725 billion—$16.125 billion to $16 billion—$16.40 billion versus a consensus of $16.03 billion.
The company affirms adjusted EPS of $11.70-$12.10 versus the consensus of $11.83 and adjusted EBITDA of $3.765 billion—$3.885 billion.
Price Action: IQV stock is down 1.87% at $149.46 at the last check on Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/05/45221976/ferrari-beats-q1-holds-2025-outlook-but-warns-tariffs-could-squeeze-profit-margins" target="_blank" rel="noreferrer noopener">Ferrari Beats Q1, Holds 2025 Outlook But Warns Tariffs Could Squeeze Profit Margins</a></li>
</ul>
Photo: Shutterstock

Health Care

General

IQVIA Beats Q1 Earnings Expectations Despite Sector Uncertainty, Company Navigating Market Conditions 'Effectively' Says CEO

WIIM

CERT

Certara shares are trading lower following Q1 reported financial results.

JP Morgan analyst Robbie Marcus maintains Zimmer Biomet Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZBH#NYSE">ZBH</a>) with a Overweight and lowers the price target from $128 to $105.

Price Target

Analyst Ratings

JP Morgan Maintains Overweight on Zimmer Biomet Holdings, Lowers Price Target to $105

Sun Communities shares are trading lower after the company reported Q1 financial results and cut its FY25 FFO guidance. Also, the company issued Q2 FFO guidance below estimates.

EXPD

Expeditors International of Washington shares are trading lower. The company reported Q1 financial results.

JP Morgan analyst Jeffrey Zekauskas maintains Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Neutral and lowers the price target from $110 to $82.

JP Morgan Maintains Neutral on Westlake, Lowers Price Target to $82

<a target="_blank" href="https://www.benzinga.com/topic/autonomous-driving" rel="noreferrer noopener">Chinese autonomous driving</a>&nbsp;Pony AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PONY#NASDAQ">PONY</a>) shares are trading higher premarket on Tuesday after the company inked a strategic deal with Uber Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) to deploy Pony.ai's <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/n45214968/pony-ai-inc-and-uber-announce-strategic-partnership-to-advance-autonomous-mobility" rel="noreferrer noopener">robotaxis onto the Uber platform</a>.
This partnership will initially launch in a key Middle Eastern market later in 2025, with plans to expand to other international markets.
Once the service is available, Uber app users in the selected market who request an eligible ride may have the option to be picked up by a Pony.ai autonomous vehicle.
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/04/45016167/pony-ai-shares-volatile-amid-strategic-tencent-partnership-and-hesai-lidar-integration-whats-going-on" rel="noreferrer noopener">Pony.ai Shares Volatile Amid Strategic Tencent Partnership And Hesai Lidar Integration: What's Going On?</a>
During this initial phase, a safety operator will be present in the vehicle until the companies achieve a fully autonomous commercial launch.
This partnership marks a significant step in Pony.ai's global expansion strategy, utilizing its existing infrastructure to demonstrate its advanced technological capabilities.
This technological progress supports the collaboration's strategic objectives, allowing Uber's platform to incorporate autonomous vehicles more rapidly and safely as the partnership extends to additional markets.
In April, Pony AI shared plans to develop autonomous driving technology in partnership with&nbsp;Tencent Holdings' Tencent Cloud and deploy robotaxi services on <a target="_blank" href="https://www.benzinga.com/media/25/04/45013465/pony-ai-and-tencent-partner-on-l4-robotaxis-expand-chinas-self-driving-future" rel="noreferrer noopener">Tencent's WeChat and other applications</a>.
Pony plans to release the first quarter 2025 results<a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener"> on May 20, 2025</a>.
Price Action: PONY shares are up 5.57% at $10.24 at the last check on Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/mid-cap/25/05/45185722/pony-ai-hims-hers-and-frontdoor-are-among-top-11-mid-cap-gainers-last-week-apr-28-may-2-are-the-others-in-your-portfolio" target="_blank" rel="noreferrer noopener">Pony AI, Hims &amp; Hers And Frontdoor Are Among Top 11 Mid-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio?</a></li>
</ul>
Photo by Tada Images via Shutterstock

Asia

Equities

Large Cap

Contracts

Movers

Tech

PONY

UBER

Robotaxis Take the Wheel As Pony AI And Uber Team Up for International Rollout

Cryptocurrency markets are anxiously anticipating Wednesday&#8217;s Federal Reserve interest rate decision, with the fear and greed index in <a href="https://www.benzinga.com/topic/cnn-business-fear-greed-index">neutral territory at 50</a>.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>24-Hour Performance</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>$94,334</td>
<td>+0.5%</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>$1,774</td>
<td>-1.6%</td>
</tr>
<tr>
<td>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>$143.46</td>
<td>-0.7%</td>
</tr>
<tr>
<td>XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>$2.11</td>
<td>-1.0%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.1674</td>
<td>-1.6%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.00001255</td>
<td>-0.7%</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul>
<li>IntoTheBlock data shows Bitcoin and Ethereum large transaction volume up by around 64% each in a single day.</li>
<li>Crypto chart analyst Ali Martinez noted almost $19 billion in capital inflows into crypto ETFs during the last 30 days.</li>
<li>Martinez also pointed to whales offloading 50,000 BTC in past ten days, implying profit-taking at current levels.</li>
</ul>
Community News: Ripple CEO Brad Garlinghouse <a href="https://x.com/bgarlinghouse/status/1919541918180245929">celebrated</a> a strong quarter for Ripple, citing the hidden road acquisition and the resolution of its SEC case. He also noted a surge in institutional demand for XRP ETPs worldwide.
On the Ethereum front, the upcoming Pectra upgrade is being closely watched. Historically, ETH has rallied ahead of major updates, but CryptoBanter <a href="https://x.com/crypto_banter/status/1919733080803209683">observed</a> that this cycle appears different, Ethereum has shown little upward movement so far.
Trader Notes: Crypto trader Michael van de Poppe <a href="https://x.com/CryptoMichNL/status/1919717281103294856">pointed</a> out that while gold is peaking ahead of the FOMC meeting, Ethereum and altcoins continue to decline. Ted Pillows flagged fresh whale buys totaling $3.1 million in ETH.
Scient <a href="https://x.com/Crypto_Scient/status/1919700644522250395">sees</a> a potential move higher but warned that a break below $1,750 could open up an opportunity to reload longs between $1,600–$1,550.
Crypto Chase is on the <a href="https://x.com/Crypto_Chase/status/1919700475844141067">sidelines</a> for Bitcoin, awaiting clearer structure or a deeper pullback before entering a long. 
For Solana, he's <a href="https://x.com/Crypto_Chase/status/1919709293533667522">watching</a> $135 as a key support level but doubts it will hold if BTC dips to $88,000. He does not expect it to hold if BTC makes a big move like $88,000, price action doesn&#8217;t have to align perfectly across assets.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> Something like this would get me very interested in a long. Don&#39;t have much of a read here, so mostly just patience for me atm. <a href="https://t.co/9E7OiUyiMS">pic.twitter.com/9E7OiUyiMS</a>
&mdash; Crypto Chase (@Crypto_Chase) <a href="https://twitter.com/Crypto_Chase/status/1919700475844141067?ref_src=twsrc%5Etfw">May 6, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Ali Martinez <a href="https://x.com/ali_charts/status/1919693874081235117">noted</a> Dogecoin is testing key support around $0.167. Holding this level could open the door for a rebound to $0.175 and possibly $0.183.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45219839/bitcoin-dips-below-94000-as-traders-eye-potential-short-term-top">Bitcoin Dips Below $94,000 As Traders Eye Potential Short-Term Top</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$DOGE

$ETH

$SHIB

$SOL

$XRP

Bitcoin, Ethereum, XRP, Dogecoin On A Knife's Edge Ahead Of Wednesday's Federal Reserve Decision

Morgan Stanley analyst Andrei Stadnik maintains Janus Henderson Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JHG#NYSE">JHG</a>) with a Equal-Weight and raises the price target from $32 to $33.

Janus Henderson Group plc Ordinary Shares

Morgan Stanley Maintains Equal-Weight on Janus Henderson Group, Raises Price Target to $33

DOCN

DigitalOcean Holdings shares are trading lower. The company reported Q2 financial results.

Webull Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BULL#NASDAQ">BULL</a>) shares are rising Tuesday after the company announced a collaboration with Visa Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>) on the <a href="https://www.benzinga.com/pressreleases/25/05/n45220739/webull-announces-collaboration-with-visa">Webull US platform</a>.
What To Know: Online investment platform Webull announced a collaboration with Visa to integrate Visa Direct on its platform, allowing its U.S. users to quickly transfer money between brokerage accounts and external bank accounts.
Visa Direct also allows for the transfer of funds directly to eligible cards and wallets. The new feature will allow Webull to offer fast access to the market through its new deposit feature, versus other common methods of transferring money, which can take several days to clear.
&#8220;Webull has always been committed to improving access to financial tools and services,&#8221; said&nbsp;Anthony Denier, Group President and U.S. CEO of Webull. 
&#8220;We are proud to work with Visa and its expansive network to enhance opportunities within financial markets. There are several exciting uses for this new capability, which will allow us to integrate technology into traditional financial services in ways that better serve Webull&#8217;s customers.&#8221;
Webull went public via a special purpose acquisition company (SPAC) merger with&nbsp;SK Growth Opportunities&nbsp;in April. The stock has seen significant interest from retail traders since its public debut. 
See Also: <a href="https://www.benzinga.com/news/25/05/45198174/robinhood-hood-stock-slips-despite-q1-earnings-beat-amid-mixed-analyst-reactions-whats-going-on">Robinhood (HOOD) Stock Slips Despite Q1 Earnings Beat Amid Mixed Analyst Reactions: What&#8217;s Going On?</a>
<h3 class="wp-block-heading">How To Buy BULL Stock</h3>
By now you're likely curious about how to participate in the market for Webull &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
BULL Price Action: <a href="http://benzinga.com/quote/bull">Webull shares</a> jumped to around $15.75 when the news was first released, before pulling back. The stock, which has been volatile in recent weeks, was up 1.55% at $14.78 at the time of publication Tuesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: <a href="https://www.shutterstock.com/g/gguy">gguy</a>/Shutterstock.

BULL

Webull Stock Charges Higher On Collaboration With Visa

XRP slid 2.57% to $2.09 on Tuesday, deepening its weekly loss to nearly 8% as traders eye <a href="https://www.benzinga.com/money/how-to-buy-ripple-xrp#:~:text=To%20purchase%20XRP%20on%20a,your%20assets%20as%20the%20custodian.">weakening momentum across the altcoin space</a>. Despite a modest 1.5% monthly gain, XRP is struggling to hold above key support levels as investor attention turns to broader macroeconomic catalysts—including this week's U.S. Federal Reserve decision.
A mixed bag of data from Ripple's first quarter XRP Markets Report points to the token's current tension. While spot trading volumes for XRP surged in the first quarter—averaging $3.2 billion daily and briefly topping $16 billion—on-chain activity on the XRP Ledger (XRPL) declined. Transactions fell more than 37% quarter-over-quarter, while wallet creations dropped 40%.&nbsp;
Even decentralized exchange activity on XRPL was down nearly 17%, with monthly DEX volume stuck around just $3.3 million, according to DefiLlama.
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/go/plus-500-crypto-in-content">Trade crypto futures on Plus500 with up to $200 in bonuses</a> — no wallets, just price speculation and free paper trading to practice different strategies.</li>
<li>New to trading crypto? <a href="http://coinbase-consumer.sjv.io/m5ALXy">Get up to $400 in rewards for successfully completing short educational courses and placing your first qualifying trade on Coinbase</a>.</li>
</ul>
The dichotomy underlines growing institutional interest in XRP—evidenced by strong inflows into XRP-based investment products and Franklin Templeton's pending ETF application—even as day-to-day user activity cools. Ripple's $1.25 billion acquisition of Hidden Road is expected to improve XRPL's on-chain utility, particularly for institutional use cases.
Meanwhile, Sentora, a newly formed institutional DeFi firm backed by Ripple and Flare, announced $25 million in Series A funding on Tuesday. The venture is a merger between IntoTheBlock and Trident Digital and aims to offer risk-managed, compliant access to DeFi yield products tailored for funds, treasuries, and large allocators.
&#8220;Through our strategic partnerships with industry leaders, we are developing a suite of products that address the key blockers preventing institutional adoption of DeFi,&#8221; Sentora CEO Anthony DeMartino said to The Block.
Despite the bullish signals, retail enthusiasm is muted. Daily volume has plummeted from December's $60 billion peak to under $8 billion. XRP's price has also tracked closely with other large-cap altcoins, with CoinDesk reporting that both ADA and XRP led losses among majors Tuesday ahead of the Fed's "coin-flip" rate decision.
However, sentiment around an eventual XRP ETF approval remains strong. Prediction platform Polymarket still shows a 76% chance of a spot XRP ETF being approved by the end of 2025 — a sign that institutional demand could eventually outweigh near-term retail fatigue.
More Opportunities:
<ul>
<li>Grow your IRA or 401(k) with Crypto – <a href="https://info.irafinancial.com/lp/irafi-crypto/?utm_source=benzinga.com&amp;utm_medium=affiliate&amp;utm_campaign=y2">unlock the power of alternative investments including a Crypto IRA within your retirement account</a>.</li>
<li>Trade, earn, and grow your crypto portfolio with Crypto.com — <a href="https://www.benzinga.com/go/crypto-com-signup-bonus">plus receive up to $500 worth of rewards in the most popular tokens if you're a new customer</a>.</li>
</ul>
Image: Shutterstock

XRP Drops to $2.09 as On-Chain Activity Sputters Despite ETF Optimism

Morgan Stanley analyst Kallum Titchmarsh maintains Inspire Medical Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INSP#NYSE">INSP</a>) with a Overweight and lowers the price target from $220 to $200.

INSP

Morgan Stanley Maintains Overweight on Inspire Medical Systems, Lowers Price Target to $200

Morgan Stanley analyst Patrick Wood maintains Glaukos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GKOS#NYSE">GKOS</a>) with a Underweight and lowers the price target from $110 to $72.

GKOS

Morgan Stanley Maintains Underweight on Glaukos, Lowers Price Target to $72

<a href="https://www.youtube.com/live/hyAdEROpMU8">https://www.youtube.com/live/hyAdEROpMU8</a>

Macro Economic Events

Politics

Economics

U.S. Treasury's Bessent Says Strategic Uncertainty Is Part Of Negotiations Over Tariffs; Asked Who Pays Tariffs, Said It's A Complicated Mix Of Factors

Morgan Stanley analyst Patrick Wood maintains GE HealthCare Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEHC#NASDAQ">GEHC</a>) with a Equal-Weight and lowers the price target from $86 to $78.

GEHC

Morgan Stanley Maintains Equal-Weight on GE HealthCare Techs, Lowers Price Target to $78

Guidance

CTRA

Watching Coterra Energy; During Conf Call Co Reportedly Says Modestly Pulling Back Some Activity In The Permian Basin And Incrementally Adding Activity In The Marcellus Shale; Expects Strong Oil Production Increases, Free Cash Flow And Rapid Deleveraging In 2025

West Texas Intermediate crude prices rebounded sharply on Tuesday, surging more than 3.6% to $59.10 per barrel by 10:00 a.m. ET, as escalating geopolitical tensions in the Middle <a href="https://www.benzinga.com/markets/commodities">East rattled energy markets</a>.
The rally came after Israeli fighter jets launched a wave of airstrikes in Yemen, targeting Houthi-controlled infrastructure, including Sanaa International Airport, in retaliation for recent missile and drone attacks on Ben Gurion Airport that left several injured.
<h3 class="wp-block-heading">War Tensions Reverse Monday's Oil Slump</h3>
The sharp rebound in oil fully reversed Monday's losses, which had been triggered by OPEC+'s decision to increase output by 411,000 barrels per day starting in June, a move that prompted Goldman Sachs to slash<a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45198741/goldman-sachs-issues-bearish-40-oil-forecast-as-opec-pumps-more-energy-stocks-sink"> its oil price forecasts.</a>
But the latest developments out of the Middle East have shifted the narrative quickly, as traders reassess supply risk in a region crucial to global oil flows.
In a statement on social media X, the Israel Defense Forces (IDF) said it struck terrorist infrastructure used by the Iran-backed Houthi regime, including power plants and logistics hubs exploited for weapons transfers and tunnel construction. 
The IDF emphasized it took steps to mitigate harm to civilians, adding, "The IDF is determined to continue operating—at any distance—against all threats posed to the citizens of the State of Israel."
<h3 class="wp-block-heading">Energy Stocks Show Muted Response</h3>
Despite the spike in crude prices, U.S. energy stocks remained broadly flat, reflecting a degree of investor caution following Monday's rout and continued uncertainty surrounding OPEC+ policy and global demand.
The Energy Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) edged up just 0.1% following a 1.8% slump a day earlier. Exxon Mobil Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) gained 1% and Chevron Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>) rose 0.2%.
Top performers within the XLE ETF included:
<ul>
<li>APA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APA#NASDAQ">APA</a>) up 1.3%</li>
<li>Occidental Petroleum Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXY#NYSE">OXY</a>) up 1.9%</li>
<li>ConocoPhillips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COP#NYSE">COP</a>) up 2.2%</li>
</ul>
Read more: 
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45220645/us-trade-deficit-soars-to-record-140b-as-imports-rocket-ahead-of-trumps-tariffs">US Trade Deficit Soars To Record $140B As Imports Rocket Ahead Of Trump&#8217;s Tariffs</a></li>
</ul>
Photo: Shutterstock

Sector ETFs

Commodities

Global

Econ #s

ETFs

Oil Soars Above $59 As Middle East Airstrikes Jolt Markets

Morgan Stanley analyst Alex Straton maintains Gap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GAP#NYSE">GAP</a>) with a Overweight and lowers the price target from $30 to $27.

Comments

Mirion Technologies

Mirion Technologies (MIR) Opzioni

Mirion Technologies (NYSE:MIR) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO